A novel negative regulatory element in the human collagenase-3 proximal promoter region

被引:12
作者
Benderdour, M [1 ]
Tardif, G [1 ]
Pelletier, JP [1 ]
Dupuis, M [1 ]
Geng, C [1 ]
Martel-Pelletier, J [1 ]
机构
[1] Cth Hosp Univ Montreal, Notre Dame Hosp, Osteoarthrit Res Unit, Montreal, PQ H2L 4M1, Canada
基金
加拿大健康研究院;
关键词
collagenase-3; promoter; gene regulation; osteoarthritis; negative regulatory element; DNA-binding protein;
D O I
10.1006/bbrc.2002.6580
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have identified in the human collagenase-3 promoter a novel negative regulatory element, GAAAAGAAAAAG, designated AGRE (AG-Rich Element). The AGRE site functionality was characterized in human osteoarthritic (OA) chondrocytes as well as four cell lines. The cells were transfected with a plasmid consisting of the first 133 bp of the collagenase-3 promoter and its AGRE mutated or deleted derivatives. The absence of a functional AGRE site resulted in a statistically significant increase of the collagenase-3 basal transcription that was not affected by the collagenase-3 inducers IL-1beta and TGF-beta1. Two specific protein-AGRE binding complexes were detected by EMSA, and their presence depended on the physiological state of the cell. Indeed, normal chondrocytes and synovial fibroblasts and the four cell lines showed only a slower-migrating complex (complex 1). In OA chondrocytes, the type of complex discriminated two groups-the low-OA chondrocytes, showing low collagenase-3 basal levels and high inducibility of IL-1beta stimulation (complex 1), and the high-OA chondrocytes with high collagenase-3 basal levels and low IL-1beta inducibility (a faster-migrating complex, designated complex 2). UV cross-linking revealed the presence of 48 and 97 kDa proteins in complex 1 and 27, 35, and 73 kDa proteins in complex 2. These findings suggest that the AGRE site plays a rate-limiting role in human collagenase-3 production. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:1151 / 1159
页数:9
相关论文
共 44 条
  • [21] 2-Y
  • [22] THE MATRIX-DEGRADING METALLOPROTEINASES
    MATRISIAN, LM
    [J]. BIOESSAYS, 1992, 14 (07) : 455 - 463
  • [23] Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO
  • [24] 2-4
  • [25] Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage
    Mitchell, PG
    Magna, HA
    Reeves, LM
    LoprestiMorrow, LL
    Yocum, SA
    Rosner, PJ
    Geoghegan, KF
    Hambor, JE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) : 761 - 768
  • [26] Moldovan F, 2000, ARTHRITIS RHEUM-US, V43, P2100, DOI 10.1002/1529-0131(200009)43:9<2100::AID-ANR22>3.0.CO
  • [27] 2-#
  • [28] Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ - In vitro mimicking effect by transforming growth factor beta
    Moldovan, F
    Pelletier, JP
    Hambor, J
    Cloutier, JM
    MartelPelletier, J
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1653 - 1661
  • [29] Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts
    Moore, BA
    Aznavoorian, S
    Engler, JA
    Windsor, LJ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1502 (02): : 307 - 318
  • [30] Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice
    Neuhold, LA
    Killar, L
    Zhao, WG
    Sung, MLA
    Warner, L
    Kulik, J
    Turner, J
    Wu, W
    Billinghurst, C
    Meijers, T
    Poole, AR
    Babij, P
    DeGennaro, LJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (01) : 35 - 44